MYELOMA MULTIPLE
Clinical trials for MYELOMA MULTIPLE explained in plain language.
Never miss a new study
Get alerted when new MYELOMA MULTIPLE trials appear
Sign up with your email to follow new studies for MYELOMA MULTIPLE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for myeloma patients with kidney failure: drug combo aims to restore kidney function
Disease control OngoingThis study compares two treatment combinations for people newly diagnosed with multiple myeloma who also have kidney failure. One group gets the standard drugs (cyclophosphamide, bortezomib, dexamethasone), while the other gets daratumumab plus bortezomib and dexamethasone. The g…
Matched conditions: MYELOMA MULTIPLE
Phase: PHASE2 • Sponsor: Eastern Cooperative Oncology Group • Aim: Disease control
Last updated May 26, 2026 07:34 UTC
-
New drug cocktail shows promise for myeloma patients ineligible for transplant
Disease control OngoingThis study tests a combination of four drugs (lenalidomide, ixazomib, dexamethasone, and daratumumab) in people newly diagnosed with multiple myeloma who cannot have a stem cell transplant. The goal is to see if adding two extra drugs to standard maintenance therapy helps keep th…
Matched conditions: MYELOMA MULTIPLE
Phase: PHASE2 • Sponsor: Alliance Foundation Trials, LLC. • Aim: Disease control
Last updated May 26, 2026 07:22 UTC
-
Engineered immune cells take aim at Hard-to-Treat multiple myeloma
Disease control OngoingThis early-phase trial tests the safety of a new gene therapy for people with multiple myeloma that has not been controlled by standard treatments. The therapy uses a patient's own immune cells (T cells) that are modified in a lab to better recognize and attack cancer cells. Abou…
Matched conditions: MYELOMA MULTIPLE
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New Shot-Based myeloma treatment shows promise in early trial
Disease control OngoingThis study tests a new way to give the drug isatuximab as a quick shot under the skin, instead of a long IV drip, for people newly diagnosed with multiple myeloma who cannot have a stem cell transplant. The treatment combines isatuximab with three standard chemotherapy drugs (bor…
Matched conditions: MYELOMA MULTIPLE
Phase: NA • Sponsor: Poitiers University Hospital • Aim: Disease control
Last updated May 19, 2026 12:01 UTC